Sign in
4

Changes in Ownership

Seres Therapeutics, Inc. Filed Acc 0000899243-16-016850

CFO and EVP sold 5,473 shares at $24.07 ($131,735)

  • CFO and EVP acquired 5,473 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Shaff Eric D. · CFO and EVP

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2016-03-28 Exercise or conversion : show line 1 in the form +5,473 $7.79 $42,635 5,473 D
2016-03-28 Sale : show line 2 in the form −5,473 $24.07 $131,735 0 D
Open-market sales · 5,473 sh · avg $24.07 · $131,735

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2016-03-28 Exercise or conversion : show line 3 in the form Stock Option (right to buy) −5,473 $7.79 2024-12-08 5,473 257,219 D
Loading xslF345X03/doc4.xml…